↑Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant(2008).„Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”.Annual Reports in Computational Chemistry4: 217-241.DOI:10.1016/S1574-1400(08)00012-1.
↑Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP.(2012).„ChEMBL: a large-scale bioactivity database for drug discovery”.Nucleic Acids Res40(Database issue): D1100-7.DOI:10.1093/nar/gkr777.PMID21948594.edit
↑Danysz W, Plaznik A, Kostowski W, Malatynska E, Järbe TU, Hiltunen AJ, Archer T(January 1988).„Comparison of desipramine, amitriptyline, zimeldine and alaproclate in six animal models used to investigate antidepressant drugs”.Pharmacology & Toxicology62(1): 42–50.PMID2965810.
↑Jäkälä P, Sirviö J, Riekkinen P, Valjakka A, Riekkinen P(1992).„The effects of alaproclate and p-chlorophenylalanine on cued navigation performance in rats”.Journal of Neural Transmission. Parkinson's Disease and Dementia Section4(1): 43–52.PMID1531758.
↑A Wilkinson, M Courtney, A Westlind-Danielsson, G Hallnemo and K E Akerman(December 1994).„Alaproclate acts as a potent, reversible and noncompetitive antagonist of the NMDA receptor coupled ion flow”.JPET271(3): 1314–1319.
↑K L Nicholson and R L Balster(2003-04-23).„Evaluation of the phencyclidine-like discriminative stimulus effects of novel NMDA channel blockers in rats”.Psychopharmacology.